Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20000402HPVENSG00000164867.11protein_codingNOS3NoNo4846P29474
TVIS20061493HPVENSG00000164867.11protein_codingNOS3NoNo4846P29474
TCGA Plot Options
Drug Information
GeneNOS3
DrugBank IDDB00435
Drug NameNitric Oxide
Target IDBE0000263
UniProt IDP29474
Regulation Typeproduct of
PubMed IDs12411399
CitationsRossig L, Li H, Fisslthaler B, Urbich C, Fleming I, Forstermann U, Zeiher AM, Dimmeler S: Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis. Circ Res. 2002 Nov 1;91(9):837-44. doi: 10.1161/01.res.0000037983.07158.b1.
GroupsApproved
Direct ClassificationOther non-metal oxides
SMILES[N]=O
PathwaysHyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Ornithine Aminotransferase Deficiency (OAT Deficiency); Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Hyperprolinemia Type I; Hyperprolinemia Type II; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; Hyperornithinemia with Gyrate Atrophy (HOGA); Prolinemia Type II; L-Arginine:Glycine Amidinotransferase Deficiency; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency
PharmGKBPA450635
ChEMBLCHEMBL1200689